Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
venBio Global Strategic Fund II L.P. Insider Profile
4 Followers
venBio Global Strategic Fund II L.P., Ten Percent Owner at VYNE Therapeutics, holds 2.16M shares in Checkmate Pharmaceuticals (Ticker: CMPI), holds 2.76M shares in Impel Pharmaceuticals (Ticker: IMPLQ), holds 3.03M shares in Akero Therapeutics (Ticker: AKRO). Most recently, venBio Global Strategic Fund II L.P. Sold ― shares of Checkmate Pharmaceuticals on May 17, 2022 for an estimated value of 1.37M.
venBio Global Strategic Fund II L.P. VYNE Therapeutics (VYNE)Ten Percent Owner
VYNE Therapeutics (VYNE)
Ten Percent Owner
Ranked #93,970 out of 98,743 Corporate Insiders
Profitable Transactions
2 out of 15 Profitable Transactions
Average Return
-33.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that venBio Global Strategic Fund II L.P. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jul 06, 2020 - Jul 06, 2021
Return:+29.40%
The most profitable trade made by venBio Global Strategic Fund II L.P.
venBio Global Strategic Fund II L.P.'s Trading History
VYNE Therapeutics
Jan 29, 2018
Ten Percent Owner
Uninformative Buy
―
$3.98M
Akero Therapeutics
Jul 06, 2020
Ten Percent Owner
Informative Sell
4.01M
$63.77M
Checkmate Pharmaceuticals
May 17, 2022
―
Informative Sell
1.37M
$22.64M
Impel Pharmaceuticals
Apr 29, 2021
―
Uninformative Buy
―
$41.40K
List of latest transactions for each holding click on a transaction to see venBio Global Strategic Fund II L.P.'s performance on stock
You May Also Like
venBio Global Strategic Fund II L.P. insider profile FAQ
What is the percentage of profitable transactions made by venBio Global Strategic Fund II L.P.?
The percentage of profitable transactions made by venBio Global Strategic Fund II L.P. is 13%.
What is the average return per transaction made by venBio Global Strategic Fund II L.P.?
The average return per transaction made by venBio Global Strategic Fund II L.P. is -33.20%.
What stocks does venBio Global Strategic Fund II L.P. hold?
venBio Global Strategic Fund II L.P. holds: VYNE, AKRO, CMPI, IMPLQ stocks.
What was venBio Global Strategic Fund II L.P.’s latest transaction?
venBio Global Strategic Fund II L.P. latest transaction was an Informative Sell of $1.37M.
What was venBio Global Strategic Fund II L.P.'s most profitable transaction?
venBio Global Strategic Fund II L.P.’s most profitable transaction was an Informative Sell of AKRO stock on July 6, 2020. The return on the trade was 29.40%.
What is venBio Global Strategic Fund II L.P.'s role in VYNE Therapeutics?
venBio Global Strategic Fund II L.P.'s role in VYNE Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.